Roth Capital sees a big upside for GeoVax after the company released promising new vaccine data. GeoVax Labs (GeoVax Labs Stock Quote, Chart, News, Analysts, Financials NSQ:GOVX) received a “Buy” rating and a $18.00 12-month price target from Roth Capital Partners analyst Jonathan Aschoff following new clinical data that supports further development of the company’s […]
IMAX (IMAX Corp Stock Quote, Chart, News, Analysts, Financials NYSE:IMAX) is setting the stage for a blockbuster year, says Roth Capital analyst Eric Handler, who maintained his Buy rating and $32 price target, citing strong first-quarter results, a booming global box office outlook, and surging demand for premium large-format screens. Handler said IMAX’s first-quarter results […]
Share
Tweet
Share
